心血管疾病患者药学评估及其干预的情况分析  

Analysis of Pharmaceutical Assessment and Intervention at Patients in Cardiovascular Disease

作　　者：徐碧云 俞平 XU Bi-yun;YU Ping(Department of Pharmacy,Lishui District People's Hospital of Nanjing City,Nanjing 211200,China)

机构地区：[1]南京市溧水区人民医院药剂科,江苏南京211200

出　　处：《中国医药指南》2020年第19期15-17,共3页Guide of China Medicine

摘　　要：目的明确我院心血管疾病患者的疾病和用药特点,发现并解决药物治疗过程中实际发生或潜在的与预期治疗结果不符的事件或情况,供临床运用及参考。方法随机抽取我院2015年~2016年心血管疾病患者的治疗药物监护病例100例对其进行药学评估,对不合理用药情况及事件进行分类统计与分析。结果被抽查的100份药物监护病例中,存在药物治疗相关问题的病例数72份,药物治疗相关问题例数108例。药物治疗相关问题及药学建议和干预情况见表1和表2。结论本研究通过规范化药学服务获取心血管疾病患者疾病和用药特点及药物治疗相关问题,向医师和患者提出合理化建议,使患者获得更加安全、经济、有效的药物治疗,避免医患矛盾的发生,规避更多的医疗风险。Objective To providing clinical use and reference.Metheds,we must clear from disease and use characteristics of patients with cardiovascular diseases,and find and solve events or situations that is actual or potential in the process of drug treatment or not tally with the expected results.Methods 100 drug monitoring cases of cardiovascular diseases,that were randomly selected in our hospital from 2015-2016,are made pharmaceutical assessment.The irrational drug use situation and events were classified and analyzed statistically.Results In 100 cases of drug monitoring,there were 72 cases of drug treatment problems and 108 drug treatment related issues.Medical treatment related issues and pharmaceutical recommendations and interventions are shown in Table 1 and table 2.Conclusion In this study,through standardized pharmacy services to obtain cardiovascular disease patients'disease and medication characteristics and drug treatment related issues,to provide rational recommendations to physicians and patients,so that patients can obtain safer,economical,and effective drug treatment,to avoid the occurrence of doctor-patient contradictions,and avoid More medical risks.

关 键 词：心血管疾病 药学评估 药学干预 

分 类 号：R969.3[医药卫生—药理学]